# 2026-13364: DEA Adds Four New Synthetic Opioids to Schedule I

2026-13364, Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act, is a Federal Register proposed rule from Justice Department, Drug Enforcement Administration published 2026-07-01, effective 2026-07-01; PRIA reads it as touching household money (as of 2026-07-08).

- Canonical: https://policyrisk.com/federal-register/2026-13364
- As of: 2026-07-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-13364
- Title: Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- Type: Proposed Rule
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 39940
- Published: 2026-07-01
- Effective: 2026-07-01
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-08

## In one line

DEA Adds Four New Synthetic Opioids to Schedule I

## Summary

Starting July 1, 2026, the DEA is temporarily putting four new substances—5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N-propionitrile chlorphine, and spirochlorphine—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move helps keep these potentially dangerous drugs off the streets while the DEA studies them further.

## Abstract

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro- 2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3- dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro desmethylchlorphine or SR-17018); 3-(3-(1-(1-(4- chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H- benzo[d]imidazol-1-yl)propanenitrile (commonly known as N-propionitrile chlorphine or cychlorphine); and 8-(1-(4-chlorophenyl)ethyl)-1-phenyl- 1,3,8-triazaspiro[4.5]decan-4-one (commonly known as spirochlorphine or R-6890), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these four specific substances.

## Effects PRIA read

- Temporary Schedule I listing for four opioids: cost, high. The DEA intends to place four synthetic opioids (5,6-dichloro brorphine; 5,6-dichloro desmethylchlorphine; N-propionitrile chlorphine; and spirochlorphine) into Schedule I. When the temporary scheduling order is published (on or after July 31, 2026) these substances will be subject to the regulator…
- Research and lab work now tightly restricted: cost, medium. If you engage in research, instructional activities, or chemical analysis involving these four substances, those activities will be subject to Schedule I regulatory controls and the associated administrative, civil, and criminal sanctions once the temporary order is published (on or after July 31,…
- Possession, manufacture, and trade subject to sanctions: cost, high. Once the DEA publishes the temporary scheduling order (on or after July 31, 2026), possessing, manufacturing, distributing, importing, or exporting these four named substances will be governed by the Schedule I controls and associated administrative, civil, and criminal sanctions. The temporary sch…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-13364 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/01/2026-13364/schedules-of-controlled-substances-temporary-placement-of-56--dichloro-brorphine-56-dichloro)
- [2026-13364 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-01/pdf/2026-13364.pdf)

## Related
- [Previous: 2026-13302, Integrated Low-Level Radioactive Waste Disposal](https://policyrisk.com/federal-register/2026-13302)
- [Next: 2026-13365, Airworthiness Directives; MD Helicopters, LLC Helicopters](https://policyrisk.com/federal-register/2026-13365)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-13364 (as of 2026-07-08).
